For instance, in bladder and cervical cancers, MEG3 overexpression has been shown to improve the efficacy of chemotherapeutic agents like cisplatin by promoting apoptosis and mitigating cellular invasion and survival pathways (121, 126). This evidence concerns the gene MEG3 and cervical cancer.